2023
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023.
Zelenetz A, Gordon L, Abramson J, Advani R, Andreadis B, Bartlett N, Budde L, Caimi P, Chang J, Christian B, DeVos S, Dholaria B, Fayad L, Habermann T, Hamid M, Hernandez-Ilizaliturri F, Hu B, Kaminski M, Karimi Y, Kelsey C, King R, Krivacic S, LaCasce A, Lim M, Messmer M, Narkhede M, Rabinovitch R, Ramakrishnan P, Reid E, Roberts K, Saeed H, Smith S, Svoboda J, Swinnen L, Tuscano J, Vose J, Dwyer M, Sundar H. NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023. Journal Of The National Comprehensive Cancer Network 2023, 21: 1118-1131. PMID: 37935098, DOI: 10.6004/jnccn.2023.0057.Peer-Reviewed Original ResearchConceptsB-cell lymphomaMantle cell lymphomaCAR T-cell therapyT-cell therapyTyrosine kinase inhibitorsFollicular lymphomaNCCN guidelinesAnti-CD19 CAR T-cell therapyRefractory B-cell lymphomaTreatment of FLBispecific T-cell engagersBruton tyrosine kinase inhibitorsLarge B-cell lymphomaNCCN Guidelines InsightsRefractory follicular lymphomaNovel immunotherapeutic approachesRelapsed Follicular LymphomaT-cell engagersTreatment landscapeImmunotherapeutic approachesFrontline settingTreatment optionsCell lymphomaLymphomaTherapy
2016
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
Daly M, Pilarski R, Axilbund J, Berry M, Buys S, Crawford B, Farmer M, Friedman S, Garber J, Khan S, Klein C, Kohlmann W, Kurian A, Litton J, Madlensky L, Marcom P, Merajver S, Offit K, Pal T, Rana H, Reiser G, Robson M, Shannon K, Swisher E, Voian N, Weitzel J, Whelan A, Wick M, Wiesner G, Dwyer M, Kumar R, Darlow S. Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. Journal Of The National Comprehensive Cancer Network 2016, 14: 153-62. PMID: 26850485, DOI: 10.6004/jnccn.2016.0018.Peer-Reviewed Original ResearchConceptsGenetic/Familial High-Risk AssessmentHigh-risk assessmentOvarian cancer risk reductionGenetic testing criteriaNCCN Guidelines InsightsCancer risk reductionRisk of breastHereditary cancer syndromesCommon genetic mutationsOvarian cancer histologiesNCCN guidelinesMultigene testingPancreatic cancerOvarian cancerCancer histologyCancer syndromesGenetic testingBreastPanel meetingGenetic mutationsPersonal historySyndromeRisk reductionCancerManagement recommendations